PASO to conduct Odonate study of new anti-cancer drug CONTESSA TRIAL Peninsula & Southeast Haematology and Oncology Research Group have commenced the Odonate Therapeutics Inc research study of the new anti-cancer drug, tesetaxel, as a possible treatment for human epidermal growth factor receptor 2 (HER2) negative, hormone receptor (HR) positive breast cancer that is locally advanced or spread … Continue reading PASO to conduct Odonate study of new anti-cancer drug